by John Conrad | Apr 7, 2020 | COVID, iBIO News
Since the March 23rd launch of the iBIO COVID-19 PPE Response Fund, the Illinois life sciences community is making a significant impact in the fight against the coronavirus. As of April 6th, the fund has received more than $760,000 in cash contributions and thousands...
by John Conrad | Apr 3, 2020 | COVID, iBIO News
Following the March 23rd launch of the iBIO COVID-19 PPE Response Fund, we are pleased to announce significant growth in the donation of funds and medical supplies from the life sciences community. Currently the fund has received more than $750,000 in cash...
by John Conrad | Apr 3, 2020 | COVID
Jim Cramer chats with outgoing Abbott Labs CEO Miles White and incoming CEO Robert Ford about the medical device maker’s development of a rapid coronavirus test that can provide results in minutes.
by John Conrad | Mar 31, 2020 | COVID, Member News
BioLife Plasma Services, part of Takeda, has implemented a unique protocol for collecting plasma from healthy individuals who have recovered from COVID-19 to enable development of a potential therapy for COVID-19, made from human plasma. You can read more about this...
by John Conrad | Mar 27, 2020 | COVID
Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as...
